The Balanced Investor Club

Diagnostics Research Industry Analysis

54 companies analyzed • Returns from -328.9% to +295.8% • Data through Mar 19, 2026

Company List (55 Results)

View:
Sort:

Industry Performance

(54/54 companies)
2025-03-21 → 2026-03-19
Weighted Avg
-0.6%
Best
+295.8%
Worst
-328.9%
Returns Distribution
Top 5
1. BDSX+295.8%2. BIAF+237.4%3. PRE+165.1%4. PRPO+140.5%5. BNR+115.3%
Bottom 5
1. WGSWW-328.9%2. NOTV-199.0%3. ISPC-192.9%4. MYNZ-169.1%5. PRPH-123.3%

BDSX

+295.8%

Biodesix Inc

BIAF

+237.4%

bioAffinity Technologies, Inc.

PRE

+165.1%

Prenetics Global Ltd

PRPO

+140.5%

Precipio Inc

BNR

+115.3%

Burning Rock Biotech Ltd

EXAS

+82.3%

EXACT Sciences Corporation

PRENW

+72.4%

Prenetics Holding Company Limited

MDXH

+71.2%

MDxHealth SA ADR

PSNL

+70.3%

Personalis Inc

GH

+65.9%

Guardant Health Inc

CHEK

+60.5%

Check Cap Ltd

GRAL

+47.0%

GRAIL, LLC

ILMN

+36.8%

Illumina Inc

MEDP

+35.2%

Medpace Holdings Inc

IDXX

+32.0%

IDEXX Laboratories Inc

NTRA

+29.4%

Natera Inc

FONR

+28.4%

Fonar Corporation

RDNT

+24.1%

RadNet Inc

CSTL

+22.5%

Castle Biosciences Inc

XWEL

+16.9%

XWELL Inc.

1–20 of 55
Page 1 of 3
Methodology

The Weighted Average return (-0.6%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

50 companies with market cap data included: BDSX, BIAF, PRE, PRPO, BNR, EXAS, MDXH, PSNL, GH, CHEK and 40 more...

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer